• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Proteinuria in sarcoidosis: Prevalence and risk factors in a consecutive outpatient cohort.结节病中的蛋白尿:连续门诊队列中的患病率及危险因素
Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):142-148. doi: 10.36141/svdld.v34i2.5297. Epub 2017 Apr 28.
2
Clinical utility of spot urine protein-to-creatinine ratio modified by estimated daily creatinine excretion in children.根据估算的每日肌酐排泄量修正的儿童随机尿蛋白与肌酐比值的临床应用价值
Pediatr Nephrol. 2017 Jun;32(6):1045-1051. doi: 10.1007/s00467-017-3587-6. Epub 2017 Feb 10.
3
Diagnostic Accuracy of Urine Protein/Creatinine Ratio Is Influenced by Urine Concentration.尿蛋白/肌酐比值的诊断准确性受尿液浓缩程度影响。
PLoS One. 2015 Sep 9;10(9):e0137460. doi: 10.1371/journal.pone.0137460. eCollection 2015.
4
Predictive value of spot versus 24-hour measures of proteinuria for death, end-stage kidney disease or chronic kidney disease progression.蛋白尿即时检测值与24小时检测值对死亡、终末期肾病或慢性肾病进展的预测价值。
BMC Nephrol. 2018 Mar 7;19(1):55. doi: 10.1186/s12882-018-0853-1.
5
Urinary protein/creatinine ratio weighted by estimated urinary creatinine improves the accuracy of predicting daily proteinuria.通过估算尿肌酐加权的尿蛋白/肌酐比值可提高预测每日蛋白尿的准确性。
Am J Med Sci. 2015 Jun;349(6):477-87. doi: 10.1097/MAJ.0000000000000488.
6
Proteinuria is a simple sign of systemic inflammation that leads to a poor prognosis in individuals affected with non-Hodgkin lymphoma.蛋白尿是全身炎症的一个简单迹象,这会导致非霍奇金淋巴瘤患者预后不良。
Clin Nephrol. 2014 Jul;82(1):51-7. doi: 10.5414/CN108132.
7
Predicting kidney transplantation outcomes using proteinuria ascertained from spot urine samples versus timed urine collections.使用即时尿液样本与定时尿液收集检测的蛋白尿预测肾移植结局。
Am J Kidney Dis. 2014 Dec;64(6):962-8. doi: 10.1053/j.ajkd.2014.07.027. Epub 2014 Oct 8.
8
The late follow-up of chronic sarcoid patients previously treated with corticosteroids.对先前接受过皮质类固醇治疗的慢性结节病患者的晚期随访。
Sarcoidosis Vasc Diffuse Lung Dis. 1998 Mar;15(1):52-8.
9
Correlation between spot and 24h proteinuria: Derivation and validation of equation to estimate daily proteinuria.点尿蛋白与 24 小时尿蛋白的相关性:估计每日蛋白尿的方程的推导和验证。
PLoS One. 2019 Apr 2;14(4):e0214614. doi: 10.1371/journal.pone.0214614. eCollection 2019.
10
A comparison of spot urine protein-creatinine ratio with 24-hour urine protein excretion in women with preeclampsia.子痫前期女性随机尿蛋白肌酐比值与24小时尿蛋白排泄量的比较。
Iran J Kidney Dis. 2008 Jul;2(3):127-31.

本文引用的文献

1
Renal sarcoidosis: epidemiological and follow-up data in a cohort of 27 patients.肾结节病:27例患者队列的流行病学及随访数据
Sarcoidosis Vasc Diffuse Lung Dis. 2015 Jan 5;31(4):306-15.
2
[Granulomatous interstitial nephritis: A retrospective study of 44 cases].[肉芽肿性间质性肾炎:44例回顾性研究]
Rev Med Interne. 2010 Oct;31(10):670-6. doi: 10.1016/j.revmed.2010.04.012. Epub 2010 Jun 3.
3
Cardiovascular implications of proteinuria: an indicator of chronic kidney disease.蛋白尿的心血管影响:慢性肾脏病的一个指标。
Nat Rev Cardiol. 2009 Apr;6(4):301-11. doi: 10.1038/nrcardio.2009.11.
4
Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients.肾结节病:47例患者的临床、实验室及组织学表现与转归
Medicine (Baltimore). 2009 Mar;88(2):98-106. doi: 10.1097/MD.0b013e31819de50f.
5
Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy.钙通道阻滞剂对糖尿病肾病患者蛋白尿的影响。
J Clin Hypertens (Greenwich). 2008 Oct;10(10):761-9. doi: 10.1111/j.1751-7176.2008.00016.x.
6
The diagnosis of sarcoidosis.结节病的诊断。
Clin Chest Med. 2008 Sep;29(3):415-27, viii. doi: 10.1016/j.ccm.2008.03.009.
7
Competing risk factor analysis of end-stage renal disease and mortality in chronic kidney disease.慢性肾脏病终末期肾病与死亡率的竞争风险因素分析
Am J Nephrol. 2008;28(4):569-75. doi: 10.1159/000115291. Epub 2008 Feb 1.
8
Testing for chronic kidney disease: a position statement from the National Kidney Foundation.慢性肾脏病检测:美国国家肾脏基金会的立场声明
Am J Kidney Dis. 2007 Aug;50(2):169-80. doi: 10.1053/j.ajkd.2007.06.013.
9
Sarcoidosis: the nephrologist's perspective.结节病:肾脏病专家的观点
Am J Kidney Dis. 2006 Nov;48(5):856-70. doi: 10.1053/j.ajkd.2006.07.022.
10
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension.
Kidney Int Suppl. 2004 Nov(92):S45-9. doi: 10.1111/j.1523-1755.2004.09212.x.

结节病中的蛋白尿:连续门诊队列中的患病率及危险因素

Proteinuria in sarcoidosis: Prevalence and risk factors in a consecutive outpatient cohort.

作者信息

Chopra Amit, Brasher Paul, Chaudhry Haroon, Zheng Robert, Asif Arif, Judson Marc A

机构信息

Department of Medicine, Pulmonary and Critical Care Medicine, Albany Medical Center, NY.

Department of Medicine, Albany Medical College, Albany, NY.

出版信息

Sarcoidosis Vasc Diffuse Lung Dis. 2017;34(2):142-148. doi: 10.36141/svdld.v34i2.5297. Epub 2017 Apr 28.

DOI:10.36141/svdld.v34i2.5297
PMID:32476835
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7170142/
Abstract

While sarcoidosis has been recognized as a potential cause of proteinuria, no study has systematically evaluated the prevalence and risk factors for proteinuria in sarcoid patients. Consecutive sarcoid patients followed in a university clinic were identified prospectively. All patients with spot urine protein-to-creatinine ratio (UPCR) between 11-2012 and 07-2015 were included in the analysis. Proteinuria was defined as a spot UPCR equal to or exceeding 0.3 mg/mg. The primary goal of the study was to determine the prevalence of proteinuria in this sarcoidosis cohort. Our study cohort consisted of 190 sarcoidosis patients (65% female, 82% white, mean age of 53 years (range 24-88)). Proteinuria was present in 14/190 (7%) of this cohort. Only5/190 patients (2.5%) had proteinuria who did not have a risk factor for proteinuria. Estimating the 24-hour urine protein excretion by extrapolating from the spot UPCR, proteinuria was moderate in amount (mean 1.60, range 0.32-5.06 mg/mg). Proteinuric patients received a lower mean daily dose of corticosteroids compared to those without proteinuria (0 mg vs 4.7 mg of prednisone); however, this difference did not reach statistical significance (p = 0.20). Our study found proteinuria in 7% of the 190 sarcoid patients. More than half of the patients with proteinuria had a known risk factor for proteinuria other than sarcoidosis. Proteinuria is uncommon in sarcoidosis, and, when it occurs, it should not be assumed that sarcoidosis is the cause without investigating alternative causes of proteinuria. .

摘要

虽然结节病已被认为是蛋白尿的一个潜在原因,但尚无研究系统评估结节病患者蛋白尿的患病率及危险因素。前瞻性地确定了在大学诊所随访的连续结节病患者。分析纳入了2012年11月至2015年7月期间所有随机尿蛋白肌酐比值(UPCR)的患者。蛋白尿定义为随机UPCR等于或超过0.3mg/mg。该研究的主要目的是确定该结节病队列中蛋白尿的患病率。我们的研究队列由190例结节病患者组成(65%为女性,82%为白人,平均年龄53岁(范围24 - 88岁))。该队列中有14/190(7%)存在蛋白尿。只有5/190例患者(2.5%)有蛋白尿且无蛋白尿危险因素。通过从随机UPCR外推估计24小时尿蛋白排泄量,蛋白尿程度为中度(平均1.60,范围0.32 - 5.06mg/mg)。与无蛋白尿患者相比,蛋白尿患者接受的皮质类固醇平均日剂量较低(泼尼松0mg vs 4.7mg);然而,这种差异未达到统计学意义(p = 0.20)。我们的研究发现190例结节病患者中有7%存在蛋白尿。超过一半的蛋白尿患者除结节病外还有已知的蛋白尿危险因素。蛋白尿在结节病中并不常见,当出现蛋白尿时,在未调查蛋白尿的其他原因之前,不应假定结节病是病因。